The Biomedical Research Institute of Vigo (INIBIV), was created on 4th December 2008, through the agreement between the SERGAS-Vigo University Hospital Complex (CHUVI), and the University of Vigo (UVIGO), aiming to promote translational research, bringing together basic, applied and clinical researchers from different disciplines.
There are now 230 people working in different fields within the INIBIV and it is managed by a Rector Council supported by the structure of the Biomedical Foundation CHUVI, the entity responsible for the management of R+D.
The research conducted at the Institute of Health Research of Vigo (INIBIV) can be summarized in 3 strategic lines developed for 5 main pathologies:
The main horizontal lines of research are:
- • Pharmacology and pharmaceutical research
- • Epidemiology and Public Health
- • Immunology
- • Cellular and Molecular Biology
On the university campus are the laboratory and classroom facilities, the Center of Scientific and Technical Support for research (CACTI) that centralizes advanced technology and provides support to the researchers with specialized personnel.
Among the equipment that is available to the CACTOS is electron microscopy (TEM, SEM, FIB), confocal microscopy, flujo cam, FTIR, mass spectrometry, Maldi-WITH TOFF, DNA sequencing, equipment for proteomics, and a laboratory of radioactive apparatuses for study of molecules and design of structures.It also counts with an animal house of 500 m², and is located in building the Biomedical Research Center (CINBIO) which will be 6,000 square meters, whose purpose is to provide researchers in infrastructure of spaces and equipment for a coordinated research.
Scientific production during the same period has resulted in more than 550 publications, 20 doctoral thesis, 6 patent solicitations and 5 technology transfer contracts. All of this shows the potencial and excellence in investigations demonstrated by the Instiute.
The Institute’s research group collaborations have been established in a network with other national centers (such as the case of networks financed by the Health Research Fund) and autonomous networks (financed by the autonomous community, or international networks) by generating a ecosystem of managed research collaboration projects.